Drug intelligence / Profile preview

xuanyunning

Development stage
Unknown
Lead developer
Guilin Sanjin Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Xuanyunning is a proprietary traditional Chinese medicine (TCM) developed and manufactured by Guilin Sanjin Pharmaceutical. It is primarily indicated for the treatment of vertigo and dizziness, particularly those arising from TCM patterns such as liver-yang hyperactivity or phlegm-dampness obstruction. The formulation is a complex herbal combination typically including *Gastrodiae Rhizoma* (Tianma), *Uncariae Ramulus Cum Uncis* (Gouteng), *Margaritifera Concha* (Zhenzhu Mu), and other botanical ingredients. These components are traditionally believed to work synergistically to "calm the liver," "extinguish wind," and "resolve dampness." Clinically, it is used to manage symptoms associated with Meniere's disease, hypertension-related dizziness, and vestibular dysfunction. It is marketed in China in oral dosage forms, including tablets and granules.

Brand names
眩晕宁Xuanyunning
Other names
眩晕宁片眩晕宁颗粒Xuanyunning PianXuanyunning Keli

Beyond the preview

Go deeper on xuanyunning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xuanyunning.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call